Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma

Author：

ISSN： 1792-1074

Source： Oncology Letters, Vol.4, Iss.6, 2012-01, pp. : 1213-1218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic value of co-expression of STAT3, mTOR and EGFR in gastric cancer

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 251-256

Spandidos Publications

Access to resources Recommend Favorite

Phosphorylated mTOR Expression is Associated with Poor Prognosis for Patients with Esophageal Squamous Cell Carcinoma

By Hirashima Kotaro

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2486-2493

Springer Publishing Company

Access to resources Recommend Favorite

Loss and reduced expression of PTEN correlate with advancedstage gastric carcinoma

Experimental and Therapeutic Medicine, Vol. 5, Iss. 1, 2013-01 ,pp. : 57-64

Spandidos Publications

Access to resources Recommend Favorite

CXCL12/CXCR4 display an inverse mRNA expression profile in gastric carcinoma that correlates with tumor progression

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 360-364

Spandidos Publications

Access to resources Recommend Favorite

pS2 Protein Expression in Gastric Carcinoma. An Immunohistochemical and Immunoradiometric Study

By Machado J.-C. Carneiro F. Ribeiro P. Blin N. Sobrinho-Simoes M.

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1585-1590

Elsevier

Access to resources Recommend Favorite